APLLTD Quarterly Results, Profit & Loss, Balance Sheet (APLLTD)

APLLTD quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • APLLTD Financials
  • APLLTD Shareholding Pattern
  • APLLTD Earnings Documents
  • APLLTD Announcements
  • APLLTD Corporate Actions
  • APLLTD Bulk, Block & Insider Deals
  • APLLTD Delivery Data
  • APLLTD Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Alembic Pharmaceuticals Ltd (APLLTD) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Alembic Pharmaceuticals Ltd reported sales of ₹2,603 Cr, operating profit of ₹562 Cr (OPM 22%) and net profit of ₹334 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

APLLTD quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales1,6931,7701,7111,9101,8761,8482,1502,603
YoY Sales growth41710161142636
Expenses1,4331,4981,4301,5941,5851,6201,8182,042
Operating Profit260271281316292228332562
OPM15%15%16%17%16%12%15%22%
Other Income101468-2721515
Interest2225242423232838
Depreciation70697476808998101
Profit before tax178192190224162119222438
Tax23%18%19%18%18%-70%22%24%
Net Profit138157154184132202172334
EPS in Rs7.047.987.859.46.7610.318.817.05
APLLTD profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,3065,6536,2296,6727,3458,477
Sales growth-271071020
Expenses4,4324,9705,2965,6646,2247,064
Operating Profit8746829321,0081,1211,413
OPM16%12%15%15%15%17%
Other Income56-22856-146
Interest1850567994112
Depreciation287275273279319367
Profit before tax625355632707694940
Tax17%4%3%18%3%-
Net Profit521342616582671840
EPS in Rs26.517.431.3329.6834.3342.92
Dividend Payout38%46%35%37%35%-
APLLTD balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital3939393939
Reserves4,7795,1525,2805,6365,905
Borrowings5131,2581,4891,4301,547
Other Liabilities1,1141,3251,5891,6582,039
Total Liabilities6,4467,7738,3978,7639,531
Fixed Assets2,5472,5242,8343,0813,293
CWIP524837903683543
Investments93127129141153
Other Assets3,2814,2854,5314,8585,542
Total Assets6,4467,7738,3978,7639,531
APLLTD cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity55272480388783
Cash from Investing Activity-372-448-321-568-506
Cash from Financing Activity-217-262-438444-164
Net Cash Flow-371445-37113
Free Cash Flow128282487-466290
CFO/OP77%115%88%16%79%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit77115881679
APLLTD ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days5668607773
Inventory Days406315350466462
Days Payable178145157179154
Cash Conversion Cycle283237253363381
Working Capital Days7477888787
ROCE11%7%13%13%13%
  • APLLTD Shareholding Pattern
  • APLLTD Earnings Concalls
  • APLLTD Growth Catalysts
  • APLLTD Corporate Actions
  • APLLTD Announcements
  • APLLTD Results & Documents
  • APLLTD Bulk & Block Deals
  • APLLTD Delivery Data